IBO
Financials
- Market Capitalization 49.6 M
- Employee 8
- Founded 2018
- CEO N/A
- Website www.impactbiomedinc.com
- Headquarter Nevada, United States
- FIGI BBG01JFZG014
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4130 |  OSTX OS Therapies Incorporated Common Stock | 1.67 USD | +2.45% | +12.08% | -2.34% | +45.22% | 74.38 M USD | ||
| 4220 |  EXOZ eXoZymes Inc. - Common Stock | 7.00 USD | +9.89% | -10.49% | -8.85% | -27.84% | 59.35 M USD | ||
| 4311 |  DWTX Dogwood Therapeutics, Inc. - Common Stock | 1.43 USD | +3.62% | +1.42% | -8.92% | -52.33% | 48.09 M USD | ||
| 4396 |  MIRA MIRA Pharmaceuticals, Inc. - Common Stock | 0.91 USD | 0.00% | -3.19% | -5.21% | -40.91% | 38.24 M USD |
Frequently asked questions about Impact BioMedical, Inc. Common Stock
What is the Impact BioMedical, Inc. Common Stock stock price today?
The current price of Impact BioMedical, Inc. Common Stock (IBO) is 0.46. Over the past 24 hours, the stock has changed by +2.22%. Follow the IBO chart for real-time price dynamics.
What is the stock ticker of Impact BioMedical, Inc. Common Stock?
Impact BioMedical, Inc. Common Stock trades under the ticker IBO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Impact BioMedical, Inc. Common Stock stock going up?
IBO has changed by 0.00% over the last week, -20.69% over the last month, and +4.05% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Impact BioMedical, Inc. Common Stock net income for the last quarter?
Impact BioMedical, Inc. Common Stock reported net income of -2.29 M for the last quarter. The previous quarter showed 5.25 M, which means net income changed by -143.60%.
How many employees does Impact BioMedical, Inc. Common Stock have?
As of the latest available data, Impact BioMedical, Inc. Common Stock has 8 employees. Workforce size can provide additional context about the company's scale and operations.
What is Impact BioMedical, Inc. Common Stock EBITDA?
Impact BioMedical, Inc. Common Stock EBITDA is -3.62 M, and its EBITDA margin is -51.77 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Impact BioMedical, Inc. Common Stock stock?
You can buy Impact BioMedical, Inc. Common Stock (IBO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Impact BioMedical, Inc. Common Stock stock?
Investing in Impact BioMedical, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IBO chart and related analysis on metatrader.com as part of your research.